EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 1,000 | -16.7% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 1,200 | +33.3% | 0.00% | – |
| Q3 2022 | $6,000 | – | 900 | -10.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1,000 | -33.3% | 0.00% | – |
| Q1 2022 | $2,000 | – | 1,500 | -25.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 2,000 | -60.8% | 0.00% | – |
| Q1 2021 | $1,000 | -85.7% | 5,100 | +24.4% | 0.00% | – |
| Q4 2020 | $7,000 | -77.4% | 4,100 | -53.8% | 0.00% | -100.0% |
| Q3 2020 | $31,000 | +158.3% | 8,880 | +688.6% | 0.00% | – |
| Q1 2017 | $12,000 | -7.7% | 1,126 | 0.0% | 0.00% | – |
| Q4 2016 | $13,000 | -13.3% | 1,126 | -0.5% | 0.00% | -100.0% |
| Q3 2016 | $15,000 | -34.8% | 1,132 | -4.8% | 0.00% | 0.0% |
| Q2 2016 | $23,000 | +21.1% | 1,189 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $19,000 | – | 1,189 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |